Introduction
The novel coronavirus pneumonia, also known as the novel coronavirus pneumonia, The subsequent global pandemic has evolved into a profound health crisis,1 with 776,546,006 confirmed cases of COVID-19 globally as of 19–10,2024….

The novel coronavirus pneumonia, also known as the novel coronavirus pneumonia, The subsequent global pandemic has evolved into a profound health crisis,1 with 776,546,006 confirmed cases of COVID-19 globally as of 19–10,2024….

Thank you, Mr. President, for this open debate.
I would like to commend and thank His Excellency Mr. Ban Ki-moon, on his own behalf and on behalf of the Elders here present, as well as Ms. Anjali Dayal for their lucid and inspiring…

Kolkata Knight Riders snapped both Matheesha Pathirana for ₹18 crore and Cameron Green for ₹25.20 crore during the IPL mini-auction held in Abu Dhabi on December 16, 2025
| Photo…

Recall Reason Description
Product has been found to contain yeast/mold and microbial contamination with one species identified as Achromobacter, at levels above specifications.
FOR IMMEDIATE RELEASE – December 16, 2025 – Albuquerque, New Mexico, MediNatura New Mexico, Inc. is voluntarily recalling all lots of ReBoost Nasal Spray to the consumer level. The product has been found to contain yeast/mold and microbial contamination with one species identified as Achromobacter, at levels above specifications. It is also recalling all lots of ClearLife Nasal Spray to the consumer level. The product has been found to contain microbial contamination that may be linked to Achromobacter at levels above specifications. This expansion has been initiated due to the company’s further investigative efforts.
Risk Statement: There is a reasonable probability that adverse health consequences including life-threatening infections will occur with use of the product in the immuno-compromised population. To date, MediNatura has not received any reports of adverse events related to this recall.
ReBoost Nasal Spray is used as a homeopathic nasal spray to temporarily relieve nasal congestion, sinus headache and pressure, postnasal drip, sneezing, runny nose, and nasal itching and is packaged in a 20mL bottle which is further packaged in a white and yellow carton. The NDC number is 62795-4005-9 and the UPC# is 787647 10186 3. The recalled ReBoost product includes all lots within expiration to ensure consumer safety [Product with Expiration date of 12/2022 to 12/2025].
ClearLife Allergy Nasal Spray is used as a homeopathic nasal spray to temporarily relieve minor allergy symptoms such as sinus pressure, runny or itchy nose, nasal congestion, allergic rhinitis, sneezing, itchy or watery eyes, allergy-related headache, and itchy throat and skin. The product is packaged in a 20mL bottle which is further packaged in a white and green carton. The NDC number is 62795-4006-9 and the UPC# is 787647 10188 7. The recalled ClearLife product includes all lot numbers within expiration to ensure the safety of consumers [Product with Expiration date of 12/2022 to 12/2025].
The products can be identified by their bottle labels and cartons:
ReBoost and ClearLife were distributed nationwide via retail and internet sales(medinatura.com).
All customers should immediately discontinue using the products under recall. Customers who purchased the product directly from MediNatura New Mexico, Inc. should contact MediNatura New Mexico, Inc. at recall@medinatura.com to arrange for a refund. Consumers who purchased the product at retailers should return it to the place of purchase.
Consumers with questions regarding this recall can contact MediNatura New Mexico, Inc by phone (800-621-7644) or recall@medinatura.com; Monday-Friday, 8:00 AM to 5:00 PM MST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Original Recall
A University of Iowa faculty member has been awarded funding from the National Institutes of Health and the National Institute on Aging to develop and test an AI chatbot that can help improve care for people with dementia.

Lemon was named to the First Team, while Fitzgerald earned Second Team honors.
Lemon and Fitzgerald have also been named to the Walter Camp…

Astronomers have used the Atacama Large Millimeter/submillimeter Array (ALMA), of which the U.S. National Science Foundation National Radio Astronomy Observatory (NSF NRAO) in a partner, together with a suite of space- and ground-based…

The non-invasive bio-logger attaches to whales using suction cups developed by Harvard robotics researchers, inspired by the anatomy of clingfish. Once deployed, the device uses three synchronised hydrophones to record…

Katie RazzallCulture and media editor
PA MediaSelf-evidently, the BBC has a big decision to make. If it hoped the US president might not follow through on his threat to sue, the reality check has arrived.
Now it is about gaming out the options but…